Ronovo Surgical
Shanghai, Shanghai, China · Biotechnology, Health Care, Manufacturing
Ronovo Surgical, founded in 2019 and based in Shanghai, is dedicated to addressing unmet clinical needs in surgery through robotic and digital innovation. Guided by the belief that flexibility, adaptability, and affordability are key to broad adoption, Ronovo developed the Carina™ Platform in close collaboration with expert surgeons, moving from concept to commercialization in just four years. The
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Shanghai, Shanghai, China
- Employees
- 26
- Industries
- Biotechnology, Health Care, Manufacturing
- Status
- Private
- Website
- ronovosurgical.com
- Company page
Recent activity at Ronovo Surgical
- : Ronovo Surgical secured $67 million in Series D financing, led by Johnson & Johnson’s JJDC with support from Lilly Asia Ventures, INCE Capital, and Granite Asia to accelerate commercialization in China.
- : Ronovo Surgical closes $44M series B financing led by Guolian Capital and INCE Capital to advance Carina™ platform towards commercialization and international expansion
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
About Ronovo Surgical: questions and answers
What does Ronovo Surgical do?
Ronovo Surgical, founded in 2019 and based in Shanghai, is dedicated to addressing unmet clinical needs in surgery through robotic and digital innovation. Guided by the belief that flexibility, adaptability, and affordability are key to broad adoption, Ronovo developed the Carina™ Platform in close collaboration with expert surgeons, moving from concept to commercialization in just four years. The
Where is Ronovo Surgical headquartered?
Ronovo Surgical is headquartered in Shanghai, Shanghai, China.
How many employees does Ronovo Surgical have?
Ronovo Surgical has about 26 employees.
What is the latest news on Ronovo Surgical?
On Sep 5, 2025, Ronovo Surgical secured $67 million in Series D financing, led by Johnson & Johnson’s JJDC with support from Lilly Asia Ventures, INCE Capital, and Granite Asia to accelerate commercialization in China.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy